New analysis of the current clinical trial landscape in the UK shows clear opportunities to shape the future of medical research and patient care. The ...

The MHRA has approved trofolastat to identify how far high-risk prostate cancer has spread before treatment, to detect ...

The World Health Organization (WHO) has confirmed the successful redesignation of the Medicines and Healthcare products ...

The MHRA has approved eplontersen (Wainzua) for treating adults with polyneuropathy associated with hereditary transthyretin ...

UK MHRA approves eplontersen to treat adults with rare inherited nerve disease or polyneuropathy: United Kingdom Monday, April 7, 2025, 15:00 Hrs [IST] The Medicines and Healthcar ...

GETTING ready for a big night out on the town meant one thing for Rich Mac – digging out a sachet of a super-strength sex drug in the hope of striking it lucky. It was a risky move ...

Infinitopes Ltd today announces that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical ...

PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Wainzua (eplontersen) to treat adults with polyneuropathy associated with hereditary transthyretin amyloidosis (ATTRv), ...

Glenmark's marketing portfolio as of December 2024 had 201 generic products authorised for distribution in the US. The ...

Generational bans, flavoured vapes, licensing. With so many changes to the tobacco and vaping landscape having been mooted ...

Researchers have reported a potential oral treatment for Alzheimer’s disease that slowed its progression over a period of at least 18 months. Developed by Singaporean company TauRx Pharmaceutics Ltd, ...